MedPath

A non-blinded randomised controlled study of the efficacy and safety of trimethoprim-sulfamethoxazole vs. norfloxacin for the prevention of spontaneous bacterial peritonitis in cirrhotic patients.

Recruiting
Conditions
Cirrhosis
Ascites
Inflammatory and Immune System - Rheumatoid arthritis
Registration Number
ACTRN12605000560695
Lead Sponsor
Austin Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Cirrhotic patient with ascites and either: 1) past history of spontaneous bacterial peritonitis, 2) ascitic protein concentration <15gm/L, 3) bilirubin >42micromol/L.

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
Ā© Copyright 2025. All Rights Reserved by MedPath